Dow Down0.62% Nasdaq Down1.14%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
159.59 Down 1.85(1.15%) 4:00PM EDT
|After Hours : 159.59 0.00 (0.00%) 4:19PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.9
Mean Recommendation (last week):1.9
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:198.65
Median Target:202.00
High Target:229.00
Low Target:156.00
No. of Brokers:20

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 26, 2012Canaccord GenuityInitiated Buy
Feb 23, 2012UBSUpgradeNeutralBuy
Feb 10, 2012Robert W. BairdUpgradeNeutralOutperform
Dec 9, 2011Barclays CapitalInitiated Overweight
Apr 25, 2011NeedhamDowngradeBuyHold
Nov 12, 2010Robert W. BairdInitiated Neutral
Oct 22, 2010JefferiesDowngradeBuyHold
Jun 3, 2010OppenheimerUpgradePerformOutperform
Jan 20, 2010OppenheimerInitiated Perform
Jul 17, 2009ThinkEquityInitiated Sell

More Upgrades & Downgrades for ALXN

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0888
Buy0777
Hold0666
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.